Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
F.A. Moraga Llop, M. Campins Martí.
Vacuna frente a la varicela: motivos para su inclusión en el calendario vacunal.
Curso del hospital 12 Octubre: Actualización en vacunas, 2002, pp. 59-77
[2.]
K. Galil, C. Brown, F. Lin, J. Seward.
Hospitalizations for varicella in the United States, 1988 to 1999.
Pediatr Infect Dis J, 21 (2002), pp. 931-934
[3.]
A. Gil, I. Oyagüez, P. Carrasco, A. González.
Epidemiology of primary varicella hospitalizations in Spain.
Vaccine, 20 (2002), pp. 295-298
[4.]
H.A. Guess, D.D. Broughton, 3.r.d. Melton LJ, L.T. Kurland.
Population-based studies of varicella complications.
Pediatrics, 7 (1986), pp. 723-727
[5.]
F.A. Moraga, A. Domínguez, J. Roca, M. Jané, N. Torner, L. Salleras, et al.
Paediatric complications of varicella requiring hospitalization.
Vacunas, 1 (2000), pp. 106-111
[6.]
C.L. Peterson, L. Mascola, S.M. Chao, J.M. Lieberman, E.L. Arcinue, D.A. Blumberg, et al.
Children hospitalized for varicella: a prevaccine review.
J Pediatr, 129 (1996), pp. 529-536
[8.]
M. Campins Martí, F.A. Moraga Llop, M. Hace referencia a Takahashi, T. Otsuka, Y. Okuno, Y. Asano, T. Yazaki, S. Isomura.
Live vaccine used to prevent the spread of varicella in children in hospital.
Lancet, 2 (1974), pp. 1288-1290
[9.]
CDC.
Prevention of varicella: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
Mmwr, 45 (1996), pp. 1-36
[10.]
R.S.J. Vessey, M.R.C.P. Dphil, C.Y. Chan, B.J. Kuter, K.M. Kaplan, M. Waters.
Childhood vaccination against varicella: persistence of antibody, duration of protection and vaccine efficacy.
J Pediatr, 139 (2001), pp. 297-304
[11.]
R.P. Wise, M.E. Salive, M.M. Braun, G.T. Mootrey, J.F. Seward, L.G. Rider, et al.
Postlicensure safety surveillance for varicella vaccine.
Jama, 284 (2000), pp. 1271-1279
[12.]
L. Salleras, J.M. Pujals, M. Salleras.
Vacuna antivaricela-zoster.
Vacunaciones preventivas. Principios y aplicaciones, pp. 311-330
[13.]
J.F. Seward, B.M. Watson, C.L. Peterson, L. Mascola, J.W. Pelosi, J.X. Zhang, et al.
Varicella disease after introduction of varicella vaccine in the United States, 1995- 2000.
Jama, 287 (2002), pp. 606-611
[14.]
J. Díez-Domingo, J. de Arístegui, F. Calbo-Torrecillas, J. González-Hachero, F. Moraga Llop, J. Peña-Guitián, et al.
Epidemiología y coste de la varicela en niños atendidos en centros de salud en España.
Vacunas Invest Pract, 2 (2001), pp. 20-24
[15.]
X.M. Pérez Porcuna, A. García Gallego, F.A. Moraga Llop.
Coste de la varicela y eficiencia de la vacunación.
Vacunas 2002, pp. 55-79
[16.]
M. Brisson, W.J. Edmunds.
The cost-effectiveness of varicella vaccination in Canada.
Vaccine, 20 (2002), pp. 1113-1125
[17.]
CDC.
Prevention of varicella. Update recommendations of the Advisory Committee on Immunization Practices (ACIP).
Mmwr, 48 (1999), pp. 1-5
[18.]
C.E. Johnson, T. Stancin, O. Fatllar, L.P. Rome, M.L. Kumar.
A long-term prospective study of varicella vaccine in healthy children.
Pediatrics, 100 (1997), pp. 761-766
[19.]
T. Ozaki, N. Nishimura, Y. Kajita.
Experience with live attenuated varicella vaccine (OKA strain) in healthy Japanese subjects: 10-year survey at pediatric clinic.
Vaccine, 18 (2000), pp. 2375-2380
[20.]
T. Varis, T. Vesikari.
Efficacy of high-titer attenuated varicella vaccine in healthy young children.
J Infect Dis, 174 (1996), pp. 330-334
[21.]
H.S. Izurieta, P.M. Strebel, P.A. Blake.
Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center.
Jama, 278 (1997), pp. 1495-1499
[22.]
M. Vazquez, P.S. LaRussa, A.A. Gershon, S.P. Steinberg, K. Freudigman, E.D. Shapiro.
The effectiveness of the varicella vaccine in clinical practice.
N Engl J Med, 344 (2001), pp. 955-960
[23.]
K. Galil, B. Lee, T. Strine, C. Carraher, A.L. Baughman, M. Eaton, et al.
Outbreak of varicella at a day-care center despite vaccination.
N Engl J Med, 347 (2002), pp. 1909-1915
[24.]
A.A. Gershon.
Varicella vaccine – Are two doses better than one?.
N Engl J Med, 347 (2002), pp. 1962-1963
[25.]
Comité Asesor de Vacunas de la Asociación Española de Pediatría.
Manual de vacunas en pediatría, pp. 316-333
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados